-
Natural Killer Cells in Brain Tumor Research
The use of Natural Killer (NK) cells, in treating human cancers, specifically brain cancers, has recently seen significant progress. NK cell therapies, in combination with other immunotherapies or treatments, hold promise for enhancing the body's natural defenses against brain tumors. Read our blog to learn why.
-
CD markers in human diseases: an informative guide
Explore the role of primary antibodies targeting CD proteins in neurobiology and cancer research. Read more to discover how these antibodies facilitate precise cell population identification in the nervous system and contribute to human cancer disease diagnosis and prognosis.
-
Research Highlights: protein markers in Glioma Research
Explore the importance of new biomarkers in glioma research and their potential to revolutionize diagnosis, prognosis, and treatment of this aggressive brain tumor. Discover new emerging biomarkers that will help to enhance patient outcomes and guide personalized therapeutic strategies.
-
Reporting from the BNA23 Neuroscience Conference
The British Neuroscience Association (BNA) hosted its 6th International Festival of Neuroscience in April. Atlas Antibodies was there promoting his catalog of primary antibodies for Neuroscience research. Were you also there? Here we briefly summarise the exciting lectures we attended this year.
-
How Neural Lineage Cells Contribute to Brain Function and Behavior
Understanding the development and progression of lineage cell types within the nervous system is critical for understanding the mechanisms of neurodegeneration and other brain diseases and can help identify potential sites for intervention. Read more and explore our primary antibodies targeting relevant markers in the neural lineage development pathways.
-
New markers targeting neuroendocrine neoplasms NENs
A neuroendocrine neoplasm (NEN) begins in the cells of the neuroendocrine system. These cells have traits of both hormone-producing endocrine cells and nerve cells. The advent of second-generation NEN markers for use in immunohistochemistry has considerably expanded the pathology toolbox for diagnosing and classifying NENs. Atlas Antibodies has released new monoclonal markers targeting NENs. Read more in our new blog post!
-
A day in the life of a scientific writer and content creator
Every career path in neuroscience can be different. Written as a Guest Blog for the British Neuroscience Association BNA, we hear from Dr. Laura Pozzi, our scientific writer, an insightful and inspiring account of her daily life at Atlas Antibodies. Read about the skills and her 3 tips for you to succeed in this job. Enjoy reading!
-
Interview with a scientist: immune resistance in lung cancer
In our new ”Interview with a Scientist” blog post, we asked Antonio Marzio, Ph.D., about his research on the mechanisms that drive immune-resistant responses in patients with non-small-cell lung carcinoma (NSCLC). Read on to learn more!
-
Research Roundup Neuroscience
Primary antibodies are a powerful tool in basic research. In our new research roundup dedicated to neuroscience, we talk about a mechanism responsible for drug resistance in epileptic patients and a newly discovered and evolutionarily conserved feature of oligodendrocytes.
-
10 ways to look at the human proteome
Antibody-based immunoassays are widely used in exploratory preclinical and pharmaceutical research as tools for discovering new druggable protein targets. Read about the 10 ways to explore and map the human proteome and how it helps researchers and clinicians on their discovery journeys.
